Medicinal Cannabis and the Psychiatric Patient: Clinical Harm vs Novel Treatment

Medicinal Cannabis and the Psychiatric Patient: Clinical Harm vs Novel Treatment

In this presentation, Dr. Diana Martinez discusses the impact of cannabis use among young adults and explores the evidence for the use of medicinal cannabis among patients with psychiatric disorders. The different forms of cannabis are discussed in terms of their therapeutic and side effects, allowing clinicians to weigh the risk—benefit ratio of cannabis use for patients.

  • Provider:Medical Academy, LLC
  • Activity Link: https://psychopharmacologyinstitute.com/publication/medicinal-cannabis-and-the-psychiatric-patient-clinical-harm-vs-novel-treatment-2614?utm_source=PARS+ACCME&utm_medium=PARS+ACCME&utm_campaign=PARS+ACCME
  • Start Date: 2022-04-01 05:00:00
  • End Date: 2022-04-01 05:00:00
  • Credit Details: AMA PRA Category 1 Credit™️: 0.75 hours
  • Commercial Support: No
  • Activity Type: Enduring Material
  • CME Finder Type: Online Learning
  • Fee to Participate: Yes
  • Measured Outcome: Learner Performance
  • Provider Ship: Jointly Provided
  • Registration: Limited
«
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x

Contact us

If you want to join leaders who will shape what Americans think about sleep.

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.

Sign up for the expert list

for media inquiries

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.